Nonetheless, as some of the presented studies have demonstrated contradicting results on the role of orexins in Alzheimer’s disease, further experiments are warranted to clarify the role of orexins in different stages of the pathogenesis and to firmly establish the therapeutic opportunities offered by orexin analogs. The gene discussed is HCRT; the disease is early-onset autosomal dominant Alzheimer disease.